首页> 外国专利> N2,N4-bis(4-(piperazin-1-yl)phenyl)pyrimidine-2,4-diamine derivatives or pharmaceutically acceptable salt thereof, and pharmaceutical composition for the prevention or treatment of cancer containing the same as an active ingredient

N2,N4-bis(4-(piperazin-1-yl)phenyl)pyrimidine-2,4-diamine derivatives or pharmaceutically acceptable salt thereof, and pharmaceutical composition for the prevention or treatment of cancer containing the same as an active ingredient

机译:N2,N4-双(4-(哌嗪-1-基)苯基)嘧啶-2,4-二胺衍生物或其药学上可接受的盐,以及包含其作为有效成分的预防或治疗癌症的药物组合物

摘要

The present invention relates to a N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or a pharmaceutically acceptable salt thereof, and to a composition containing same as an active ingredient for preventing or treating cancer. Since the compound according to the present invention has good effects in inhibiting the activities of anaplastic lymphoma kinase (ALK) and activated Cdc42-associated kinase (ACK1), the compound can have improved therapeutic effects against cancer cells having ALK fusion proteins such as EML4-ALK and NPM-ALK and is expected to be effective in preventing the recurrence of cancer. Therefore, the compound can be effectively used as a composition for preventing or treating cancer.
机译:本发明涉及一种N2,N4-双(4-(哌嗪-1-基)苯基)嘧啶-2,4-二胺衍生物或其药学上可接受的盐,以及涉及含有该化合物作为预防活性成分的组合物。或治疗癌症。由于本发明的化合物在抑制间变性淋巴瘤激酶(ALK)和活化的Cdc42相关激酶(ACK1)的活性方面具有良好的作用,因此该化合物对具有ALK融合蛋白如EML4-的癌细胞可以具有改善的治疗作用。 ALK和NPM-ALK有望有效预防癌症复发。因此,该化合物可以有效地用作预防或治疗癌症的组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号